Virios Therapeutics Inc (VIRI)
0.3514
-0.03
(-8.96%)
USD |
NASDAQ |
May 17, 16:00
0.2415
-0.11
(-31.27%)
After-Hours: 20:00
Virios Therapeutics Price to Book Value: 2.549 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 2.549 |
| May 16, 2024 | 2.800 |
| May 15, 2024 | 2.949 |
| May 14, 2024 | 2.771 |
| May 13, 2024 | 2.569 |
| May 10, 2024 | 2.575 |
| May 09, 2024 | 2.703 |
| May 08, 2024 | 3.112 |
| May 07, 2024 | 2.996 |
| May 06, 2024 | 2.974 |
| May 03, 2024 | 2.985 |
| May 02, 2024 | 3.056 |
| May 01, 2024 | 3.191 |
| April 30, 2024 | 3.279 |
| April 29, 2024 | 3.408 |
| April 26, 2024 | 3.406 |
| April 25, 2024 | 3.307 |
| April 24, 2024 | 3.085 |
| April 23, 2024 | 3.127 |
| April 22, 2024 | 3.088 |
| April 19, 2024 | 3.159 |
| April 18, 2024 | 3.264 |
| April 17, 2024 | 3.271 |
| April 16, 2024 | 3.279 |
| April 15, 2024 | 3.417 |
| Date | Value |
|---|---|
| April 12, 2024 | 3.717 |
| April 11, 2024 | 3.482 |
| April 10, 2024 | 3.374 |
| April 09, 2024 | 3.369 |
| April 08, 2024 | 3.268 |
| April 05, 2024 | 3.323 |
| April 04, 2024 | 3.490 |
| April 03, 2024 | 3.569 |
| April 02, 2024 | 3.918 |
| April 01, 2024 | 4.208 |
| March 28, 2024 | 2.424 |
| March 27, 2024 | 2.447 |
| March 26, 2024 | 2.176 |
| March 25, 2024 | 2.377 |
| March 22, 2024 | 2.314 |
| March 21, 2024 | 1.678 |
| March 20, 2024 | 1.776 |
| March 19, 2024 | 1.791 |
| March 18, 2024 | 1.619 |
| March 15, 2024 | 1.609 |
| March 14, 2024 | 1.669 |
| March 13, 2024 | 1.588 |
| March 12, 2024 | 1.588 |
| March 11, 2024 | 1.864 |
| March 08, 2024 | 1.867 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4689
Minimum
Dec 30 2022
10.23
Maximum
Sep 16 2022
2.850
Average
2.316
Median
Price to Book Value Benchmarks
| CEL-SCI Corp | 4.808 |
| AIM ImmunoTech Inc | 2.107 |
| IGC Pharma Inc | 3.942 |
| NovaBay Pharmaceuticals Inc | -- |
| Protalix BioTherapeutics Inc | 2.806 |
Price to Book Value Related Metrics
| Price | 0.3514 |
| Earnings Yield | -76.84% |
| Market Cap | 6.767M |